another news portal
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that lines the alveoli and
A radio show in Congo is trying to battle misinformation around an ongoing Ebola outbreak
A quarter of all babies in England are now delivered by emergency caesarean operations, BBC analysis shows – marking a significant rise over the last
As easily predicted, declining measles vaccine rates in the US is leading directly to surging measles cases. In 2025 we saw the highest measles cases
The shift marks a significant rise over the last five years, but experts say there is no single, clear explanation for the increase.
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
Postpartum and perinatal depression are known challenges for those going through pregnancy, but there has been less focus on the more prevalent disorder of anxiety.
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other regulatory proteins that control gene activity
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a quest to research a link between
Announcing a new article publication for Cardiovascular Innovations and Applications journal. The long-term effects of sustained weight gain and loss on atrial fibrillation (AF) risk
Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the European Research Council (ERC), have identified a
Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether
Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells to remain hidden for years
Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed a topical gel formulation with 4-aminopyridine (4-AP)
